Biruni University Advanced Technology Application and Research Center Regulation
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This regulation sets the purpose, activities, management structure, and working rules for Biruni University’s Advanced Technology Application and Research Center. The center is designed to bring together research in health sciences, medicine, pharmacy, engineering, biotechnology, AI, materials technology, and related fields. Its work will mainly affect Biruni University researchers, partner universities, industry partners, and organizations involved in advanced technology and health-focused R&D.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Creates the operating framework for Biruni University’s Advanced Technology Application and Research Center.
- Defines the center’s research focus, including advanced technology, health sciences, biotechnology, AI, materials technology, and drug development.
- Sets rules for the center’s management bodies, duties, and working methods.
Obligations
What this law requires
Biruni University Advanced Technology Application and Research Center must examine current developments in science and advanced technology and increase the qualitative and quantitative productivity of research through national and international scientific collaborations.
The Center must cooperate with domestic and foreign public institutions, private sector organizations, and application and research centers that operate in fields aligned with the Center’s purposes.
The Center must contribute to the development of graduate programs in fields related to its activities.
The Center must conduct clinically translatable studies and produce projects enabling researchers from medicine, basic sciences, pharmacy, health sciences, and engineering to work together to obtain new scientific data and develop treatment products for disease diagnosis and treatment.
The Center must develop new and original molecules, new-generation medicines, products, methods, systems, and drug delivery systems based on advanced and innovative technology for use in disease diagnosis and treatment.